<code id='90D42AA769'></code><style id='90D42AA769'></style>
    • <acronym id='90D42AA769'></acronym>
      <center id='90D42AA769'><center id='90D42AA769'><tfoot id='90D42AA769'></tfoot></center><abbr id='90D42AA769'><dir id='90D42AA769'><tfoot id='90D42AA769'></tfoot><noframes id='90D42AA769'>

    • <optgroup id='90D42AA769'><strike id='90D42AA769'><sup id='90D42AA769'></sup></strike><code id='90D42AA769'></code></optgroup>
        1. <b id='90D42AA769'><label id='90D42AA769'><select id='90D42AA769'><dt id='90D42AA769'><span id='90D42AA769'></span></dt></select></label></b><u id='90D42AA769'></u>
          <i id='90D42AA769'><strike id='90D42AA769'><tt id='90D42AA769'><pre id='90D42AA769'></pre></tt></strike></i>

          knowledge

          knowledge

          author:leisure time    Page View:674
          Influenza A virions
          F. A. Murphy/CDC

          Vir Biotechnology said Thursday that a long-acting antibody drug designed to protect healthy individuals from influenza A failed to do so in a nearly 3,000-person clinical trial.

          Volunteers who received the highest dose of the drug, known as VIR-2482, were only 16% less likely than the placebo group to develop symptomatic influenza A infections, as defined by trial criteria, over a seven-month period. The difference was not statistically significant.

          advertisement

          The results are a setback in broader efforts to develop better protective measures against both seasonal and potential pandemic influenza strains. In the short term, Vir and outside experts hoped VIR-2482 could provide additional annual protection for at-risk groups like older adults, as flu vaccines are often only modestly effective.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          knowledge

          Hepatitis C has a cure — but many Americans still lack access to it
          Hepatitis C has a cure — but many Americans still lack access to it

          AdobeIn2005,NickVoyleswasdiagnosedwithhepatitisCafterbeingreleasedfromfiveyearsofincarceration.Anurs

          read more
          How generative AI ratchets up security threats for health systems
          How generative AI ratchets up security threats for health systems

          AdobeTheubiquityofAItoolslikeChatGPTcouldbeaboontohospitalseagerfordiagnosticaidsoradministrativeass

          read more
          23andMe had bad news about my health. I wish a person had delivered it
          23andMe had bad news about my health. I wish a person had delivered it

          ERICBARADAT/AFP/GettyImagesLastsummer,IthoughtitmightbefuntohavemyDNAanalyzed.Twocompanies,23andMean

          read more

          Humana’s losses in Medicare Advantage tank its stock

          Humana’sMedicareAdvantagebusinessisfaringevenworsethanthecompanyletonlastweek.EdReinke/APHumana’sMed